Charles River Laboratories CRL Defined Benefit Plan Actuarial Gain Loss
Defined Benefit Plan Actuarial Gain Loss at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPlanActuarialGainLoss.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's defined benefit plan actuarial gain loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's defined benefit plan actuarial gain loss?
- Charles River Laboratories (CRL) reported defined benefit plan actuarial gain loss of $2.08M in Q4 2025.
- How has Charles River Laboratories's defined benefit plan actuarial gain loss changed year-over-year?
- Charles River Laboratories's defined benefit plan actuarial gain loss decreased by 22.1% year-over-year, from $2.67M to $2.08M.
- What does defined benefit plan actuarial gain loss mean?
- Reflects changes in the estimated value of the defined benefit obligation due to differences between actual experience and actuarial assumptions. This includes changes in discount rates, mortality tables, or demographic projections that impact the present value of future benefits.